Constipation Is Costly

Published Online: Monday, August 1, 2005

Chronic constipation often is associated with symptoms that negatively affect patients' daily lives, as well as with frequent use of the health care system. At the recent Digestive Diseases Week conference, B. Martin, PharmD, and colleagues demonstrated the high direct costs associated with constipation (not including OTC and prescription drugs) in outpatient and inpatient settings. The results showed that 2.7 million physician visits were made in 2001 where constipation was the primary diagnosis or reason for the consultation: 1,838,493 visits to physician offices, 297,927 visits to hospital outpatient centers, 555,432 visits to the emergency room, and 38,361 inpatient visits. The annual cost totaled $235 million, 55% of which was incurred in the inpatient setting.

G. Singh, MD, and colleagues demonstrated that patients with constipation are more likely to experience complications and comorbidities. In this study, patients with constipation were compared with a random 20% sample of all MediCal enrollees without constipation. Patients with constipation were more likely to experience comorbid irritable bowel syndrome and constipation-associated complications such as impaction, fissures, and volvulus.

Latest Articles
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Latest Issues